Home / Recalls / AbbVie Inc. / D-0833-2016

D-0833-2016 Class III Terminated

Recalled by AbbVie Inc. — North Chicago, IL

Recall Details

Product Type
Drugs
Report Date
April 27, 2016
Initiation Date
March 24, 2016
Termination Date
October 20, 2016
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
307 bottles

Product Description

Zemplar (paricalcitol) capsules, 1 mcg, 30-count bottle, Rx Only, Mfd for AbbVie Inc. North Chicago, IL 60064, NDC 0074-4317-30.

Reason for Recall

Failed Content Uniformity Specifications

Distribution Pattern

Nationwide

Code Information

Lot #1055586, Exp.1/21/ 2018

Other recalls by AbbVie Inc.

  • D-0664-2024 Class II — Refresh P.M., (Mineral Oil 42.5%, White Petrolatum 57.3%) Lubricant Eye Ointment (September 16, 2024)
  • D-0665-2024 Class II — Refresh LACRI-LUBE, (42.5% Mineral Oil, 57.3% White Petrolatum) Lubricant Eye Oi (September 16, 2024)
  • D-0088-2024 Class III — Synthroid, Levothyroxine Sodium Tablets, USP 125mcg (0.125mg), 100-count bottle, (October 17, 2023)
  • D-0412-2018 Class III — Ultane (sevoflurane), 250 mL, Inhalation Anesthetic, Rx only, Manufactured by: (January 22, 2018)
  • D-0033-2018 Class III — AndroGel (testosterone gel) 1.62%, 88 gm metered-dose pump, 20.25 mg of testoste (September 8, 2017)
  • D-0034-2018 Class III — AndroGel (testosterone gel) 1.62%, 40.5mg in 2.5g aluminum foil packet, 30 Packe (September 8, 2017)
  • Z-2177-2017 Class II — AbbVie PEG, PEG Kit 15FR, FOR ENTERAL USE ONLY, STERILE, Rx Only. (April 27, 2017)
  • Z-2176-2017 Class II — AbbVie PEG, PEG Kit 20FR, FOR ENTERAL USE ONLY, STERILE, Rx Only. (April 27, 2017)
  • Z-2178-2017 Class II — AbbVie PEG, PEG Kit 15FR, FOR ENTERAL USE ONLY, STERILE, Rx Only. (April 27, 2017)
  • D-0495-2017 Class II — Duopa (carbidopa and levodopa enteral suspension), 4.63 mg/20 mg per mL, 100 mL (January 13, 2017)